Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics

NCT03556683 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DEVICE: 3% Hypertonic Saline
DEVICE: 7% Hypertonic Saline
DRUG: Salbutamol

Sponsor

University of North Carolina, Chapel Hill

Collaborators

[object Object]